News

Hepatitis outlook: July 2016


 

References

Sustained virologic response can be attained with pegylated interferon-alpha plus ribavirin combination therapy in hepatitis C virus–infected patients, but a relapse may occur in some patients, according to a recent study.

A quantitative HBsAg test can be used to ascertain high levels of hepatitis B viremia in women who might transmit the virus to their children, rather than a test for HBeAg or HBV DNA, according to a research letter in Hepatology.

A Chinese study found a robust relationship between Helicobacter pylori infection and chronic hepatitis B. This is especially true during hepatitis B virus progression.

The prevalence of antihepatitis E virus (HEV) antibodies was 49% (153/313) among blood donors in central Italy, according to a study published in Eurosurveillance. The authors said HEV infection is hyperendemic among blood donors (80% men, 18- to 64-years-old) from central Italy and associated with local dietary habits, such as eating raw dried pig liver sausage.

rpizzi@frontlinemedcom.com

On Twitter @richpizzi

Pages

Recommended Reading

VIDEO: Nearly half of Medicaid patients denied antivirals for HCV
MDedge Infectious Disease
Early sustained viral response linked to better outcomes among HCV patients
MDedge Infectious Disease
FDA approves Epclusa for patients with chronic hepatitis C
MDedge Infectious Disease
Novel vaccine scores better hepatitis B seroprotection in type 2 diabetes
MDedge Infectious Disease
HBV/HIV coinfection a significant risk factor for inpatient mortality
MDedge Infectious Disease
Hepatitis Outlook: June 2016
MDedge Infectious Disease
HIV patients with elevated ALT at significant risk of chronic liver disease
MDedge Infectious Disease
Hepatitis disease burden continues to rise
MDedge Infectious Disease
Hepatitis C infection rates rising in women, young children
MDedge Infectious Disease
WHO analysis: Cost of new HCV meds unaffordable globally
MDedge Infectious Disease